Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698840 · ClinicalTrials.gov registry record · NA
Effect of Vitamin D in Diets of Preterm Infants
A NA study of Premature Infants, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT01698840: Completed NA study of Premature Infants, sponsored by Baylor College of Medicine.
NCT01698840 is a NA study of Premature Infants that has completed, run by Baylor College of Medicine. The registered enrollment target is 39 participants, below the 247-participant average among 4 other Premature Infants trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01698840, a NA study of Premature Infants, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
Transitional formulas (22 kcal/oz) are recommended for infants less than 35 weeks gestation at birth. However, few data are available related to follow-up of infants receiving these formulas who were 28-34 weeks gestation at birth. Primary hypothesis: Provision of supplemental vitamin D to a transitional formula will lead to higher serum 25-hydroxyvitamin D (25-OHD) levels and no infant with a serum 25-OHD less than 20 ng/mL when assessed at approximately 52 weeks post-menstrual age (PMA).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D
Study Locations (1)
Texas
- Baylor College of Medicine / Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-07-30 |
| Phase | NA |
What the finished NCT01698840 record still lists
NCT01698840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 247-participant average among 4 other Premature Infants trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Premature Infants appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01698840 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01698840 about?
NCT01698840 is a clinical study titled "Effect of Vitamin D in Diets of Preterm Infants". Transitional formulas (22 kcal/oz) are recommended for infants less than 35 weeks gestation at birth. However, few data are available related to follow-up of infants receiving these formulas who were 28-34 weeks gestation at birth. Primary hypothesis: Provision of supplemental vitamin D to a transi...
What is the current status of trial NCT01698840?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2013-01. Estimated completion is 2016-07-30.
What conditions does trial NCT01698840 study?
This clinical trial studies the following conditions: Premature Infants.
What interventions are being tested in trial NCT01698840?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01698840?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01698840 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Infants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
RECRUITING · NA
-
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
RECRUITING · NA
-
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
COMPLETED · NA
-
NIRS Monitoring in Premature Infants
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia